Back

A geriatric assessment score for predicting one-year survival after transcatheter aortic valve implantation: the multicenter GASS-TAVI study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Predictors of TAVI outcomes Aortic Valve Stenosis ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Carlo Fumagalli

University of Campania Luigi Vanvitell, Naples (Italy)

5 More presentations in this session

Presentation thumbnail
Improving risk stratification in TAVI: the role of epicardial fat, visceral fat and adiponectin
Doctor T. Storozhenko (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes and predictors of mortality in TAVI patients with high, low and very low baseline gradient. Analysis of the Spanish TAVI registry
Doctor J. De La Torre Hernandez (Santander, ES)
Abstract Slides Video
Presentation thumbnail
Periprocedural, early, and late outcomes following transcatheter aortic valve replacement in patients with severe aortic atheroma
Doctor S. Kikuchi (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Impact of conduction disturbances persistency on 2-year outcomes after transcatheter aortic valve implantation
Doctor S. Okita (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Skirted prosthetic valves are associated with increased risk of subclinical leaflet thrombosis following transcatheter aortic valve replacement: a multicenter study
Doctor Y. Yang (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Predictors of TAVI outcomes
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Aortic stenosis in patients over 80 years old: TAVI for all patients? How to select different indications
thumbnail
Congress Presentation
Factors associated with futility in transcatheter aortic valve replacement: a single-center analysis
thumbnail
Congress Presentation
Cardiovascular diseases in older adults - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources